Patient and Physician Perspectives on Non-Alcoholic Fatty Liver Disease
2 other identifiers
observational
17
1 country
1
Brief Summary
This trial studies patient and physician perspectives on non-alcoholic fatty liver disease. Using questionnaires and interviews, this trial may help researchers understand physicians' knowledge about the diagnosis, prognosis, treatment and management of non-alcoholic fatty liver disease, as well as gain an in-depth understanding of Hispanic patients' perceptions about the disease and investigate how cultural factors may play a role in its diagnosis, treatment and management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 22, 2019
CompletedFirst Submitted
Initial submission to the registry
October 4, 2019
CompletedFirst Posted
Study publicly available on registry
October 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2030
February 19, 2026
February 1, 2026
10.7 years
October 4, 2019
February 17, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Explore the perceptions of NAFLD, including knowledge, current practices for diagnosis and management, and additional disease-related perceptions amongst both primary care physicians (Questionnaire)
Up to 1 year
Explore the perceptions of NAFLD, including knowledge, diagnosis and management, and additional disease-related perceptions amongst Hispanic patients. (Questionnaire)
Up to 1 year
Study Arms (1)
Observational (questionnaire, interview)
Patients and physicians complete a questionnaire over 5 minutes and an interview over 30-45 minutes about thoughts on NAFLD, including what they know about NAFLD and its diagnosis, management, and monitoring, and other thoughts on NAFLD.
Interventions
Eligibility Criteria
Hispanic patients with NAFLD from the Greater Houston Metropolitan Area and practicing physicians, who are primary care physicians (internal medicine, family medicine, etc.)
You may qualify if:
- Be a self-reported practicing physician, who is a primary care physician (internal medicine, family medicine, etc.)
- Self-reported Hispanic ethnicity from the Greater Houston Metropolitan Area (patient)
- Have been diagnosed with NAFLD by a doctor (patient)
- Be an adult \>/= 18 (patient)
- Able to speak English (patient)
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- M.D. Anderson Cancer Centerlead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lorna McNeill
M.D. Anderson Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 4, 2019
First Posted
October 18, 2019
Study Start
August 22, 2019
Primary Completion (Estimated)
May 1, 2030
Study Completion (Estimated)
May 1, 2030
Last Updated
February 19, 2026
Record last verified: 2026-02